5Le Chevalier T. Randomizedstudy of vinorelbine andcisplatin wersus vindesine and cisplatin versusvinorelbine alone in advanced non2small2cell lung cancer:resuh s of aEuropean multicenter t rialI including 612 patient[J]. J Clin Oncol, 1994,1 (2) :360 - 367.
4Tan EH, Ang PT, Wee J, et al . Vinorelbine, ifosfamide and cisplatin in advanced non-small cen lung cancer[J]. Acta Oncol, 1999, 38: 619-622.
5Ganz PA, Figlin RA, Haskell CM, et al. Supportive care venus supportive care and chemotherapy in metastatic non-samll-cell lung cancer: Doses chemotherapy make a difference [ J ]?Cancer, 1998,63( 1 ) : 1271-1278.
6Rapp EA, Pater JL, William A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer Report d a canadian multicenter randomized trial[J]. J Clin Oncol,1998,6(3):633-641.
7Non-small-cell Cancer Collaborative Group. Chemotherapy in non-small-cell lung cancer: a mata-analysis using updated data on individual patients from 52 randomized clinical trails [ J ].BMJ, 1995,311 (5) :899-909.
8Klasterku J, Sculier J, Bureau G, et al. Cisplatin versus cisplatin plus etoptside in the treatment of advanced non-samll-cell lung cancer. Lung Cancer Working Party, Belgium [ J ]. J Clin Oncol,1989,7(6) :1087-1092.
9Paul A, Bunn PAJr, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in Non-small-cell lung cancer:a review of the literature and future directions[J].Clin Cancer Res, 1998 ,5 ( 5 ) : 1087 -1100.
10Chevalier TL, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin venus videsine and cisplatin versus vimorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trail including 612 patients[J]. J Clin Oncol, 1994,12( 1 ) :306-307.
